Silvercrest Asset Management Group LLC Amicus Therapeutics, Inc. Transaction History

Silvercrest Asset Management Group LLC

$14.6 Billion
Q4 2024

A detailed history of Silvercrest Asset Management Group LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 535,255 shares of FOLD stock, worth $5.23 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

535,255

Previous 537,639 0.44%

Holding current value

$5.23 Million

Previous $5.74 Million 12.18%

% of portfolio

0.03%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$9.36 - $12.01 $22,314 - $28,631	-2,384 Reduced 0.44%	535,255 $5.04 Million
Q3 2024 Nov 14, 2024	SELL	$9.55 - $12.09 $29,595 - $37,466	-3,099 Reduced 0.57%	537,639 $5.74 Million
Q2 2024 Aug 14, 2024	SELL	$9.04 - $11.75 $4.89 Million - $6.35 Million	-540,738 Reduced 50.0%	540,738 $5.36 Million
Q2 2024 Aug 14, 2024	BUY	$9.04 - $11.75 $6.39 Million - $8.3 Million	706,518 Added 188.43%	1,081,476 $10.7 Million
Q1 2024 May 15, 2024	BUY	$11.43 - $14.24 $183,257 - $228,309	16,033 Added 4.47%	374,958 $4.42 Million
Q4 2023 Feb 14, 2024	SELL	$9.97 - $14.52 $737 - $1,074	-74 Reduced 0.02%	358,925 $5.09 Million
Q3 2023 Nov 14, 2023	BUY	$11.78 - $13.86 $926,084 - $1.09 Million	78,615 Added 28.04%	358,999 $4.37 Million
Q2 2023 Aug 14, 2023	BUY	$10.72 - $13.3 $444,751 - $551,790	41,488 Added 17.37%	280,384 $3.52 Million
Q1 2023 May 15, 2023	SELL	$10.91 - $13.54 $2,061 - $2,559	-189 Reduced 0.08%	238,896 $2.65 Million
Q4 2022 Feb 14, 2023	SELL	$9.89 - $12.7 $1.78 Million - $2.28 Million	-179,838 Reduced 42.93%	239,085 $2.92 Million
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $105,142 - $136,514	-10,707 Reduced 2.49%	418,923 $4.37 Million
Q2 2022 Aug 15, 2022	SELL	$6.23 - $11.12 $135,365 - $241,615	-21,728 Reduced 4.81%	429,630 $4.61 Million
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $38,653 - $61,139	4,899 Added 1.1%	451,358 $4.27 Million
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $15,378 - $19,481	1,566 Added 0.35%	446,459 $5.16 Million
Q3 2021 Nov 15, 2021	SELL	$8.74 - $11.84 $72,209 - $97,822	-8,262 Reduced 1.82%	444,893 $4.25 Million
Q2 2021 Aug 16, 2021	BUY	$8.71 - $10.72 $1.29 Million - $1.59 Million	147,980 Added 48.49%	453,155 $4.37 Million
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $1.21 Million - $3.13 Million	131,253 Added 75.47%	305,175 $3.02 Million
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $373,846 - $690,797	-27,754 Reduced 13.76%	173,922 $4.02 Million
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $46,648 - $57,505	-3,619 Reduced 1.76%	201,676 $2.85 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $1.82 Million - $3.22 Million	205,295 New	205,295 $3.1 Million

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

311M

Call Options Held

504K

Put Options Held

515K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.74B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.

Account

Silvercrest Asset Management Group LLC Amicus Therapeutics, Inc. Transaction History